Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112 | |
Dong, Dong[1]; Wang, Xiao[1]; Wang, Huailing[1]; Zhang, Xingwang[2]; Wang, Yifei[1]; Wu, Baojian[2] | |
2015 | |
卷号 | 10期号:[db:dc_citation_issue]页码:2521 |
DOI | [db:dc_identifier_doi] |
URL标识 | 查看原文 |
WOS记录号 | [DB:DC_IDENTIFIER_WOSID] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3347852 |
专题 | 暨南大学 |
作者单位 | 1.[1]Jinan Univ, Coll Pharm, Guangzhou Jinan Biomed Res & Dev Ctr, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Jinan Univ, Coll Pharm, Div Pharmaceut, Guangzhou 510632, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Dong, Dong[1],Wang, Xiao[1],Wang, Huailing[1],et al. Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112[J],2015,10([db:dc_citation_issue]):2521. |
APA | Dong, Dong[1],Wang, Xiao[1],Wang, Huailing[1],Zhang, Xingwang[2],Wang, Yifei[1],&Wu, Baojian[2].(2015).Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.,10([db:dc_citation_issue]),2521. |
MLA | Dong, Dong[1],et al."Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112".10.[db:dc_citation_issue](2015):2521. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论